Understanding the burden of human papillomavirus-associated anal cancers in the US

2008205 citationsJournal Articlehybrid Open Access

Authors

Djenaba Joseph · National Center for Chronic Disease Prevention and Health Promotion

Jacqueline W. Miller · Centers for Disease Control and Prevention

Xiao‐Cheng Wu · Louisiana State University Health Sciences Center New Orleans

Vivien W. Chen · Louisiana State University Health Sciences Center New Orleans

Cyllene R. Morris · Public Health Institute

Marc T. Goodman · University of Hawaii System

Abstract

Rates of anal SCC varied by sex, race, and ethnicity. A higher proportion of API were diagnosed at regional/distant stage. Men had lower 5-year survival rates than women. Continued surveillance and additional research are needed to assess the potential impact of the HPV vaccine on the anal cancer burden in the US.

Topics & Keywords

Colorectal and Anal Carcinomas Cervical Cancer and HPV Research Surgical site infection prevention

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 113, Issue S10, pp. 2892-2900

DOI: 10.1002/cncr.23744

Field-Weighted Citation Impact: 13.82